SBIA
CRMD icon

Sheaff Brock Investment Advisors’s CorMedix CRMD Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$25K – 617
2016
Q3 		$25K Buy
+2,000
New +$18.7K ﹤0.01% 548

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sheaff Brock Investment Advisors's CRMD Position: Q4 2016 in Review

Sheaff Brock Investment Advisors sold out of CorMedix (CRMD) in Q4 2016, closing a stake of 2,000 shares — an estimated $25K sold.

Sheaff Brock Investment Advisors first reported a position in CRMD in Q3 2016 and held it in 1 quarter. The position peaked at $25K in Q3 2016. 38 funds tracked by Wall St. Rank hold CRMD as of Q4 2016.

  • Sheaff Brock Investment Advisors reported no remaining CorMedix position as of Q4 2016 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 2,000 CorMedix shares in Q4 2016, an estimated $25K.
  • Sheaff Brock Investment Advisors first reported a position in CorMedix in Q3 2016 and held it in 1 quarter.
  • Sheaff Brock Investment Advisors's CorMedix position peaked at $25K in Q3 2016.
  • 38 funds tracked by Wall St. Rank held CorMedix as of Q4 2016.

Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.